Levofloxacin Krka (Levofloxacin)

Levofloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. Inhibition of these enzymes prevents DNA supercoiling and separation, leading to bacterial cell death and a bactericidal effect across a broad spectrum of pathogens.

The dosage of Levofloxacin Krka is determined by the prescribing clinician based on the infection type, severity, patient age, renal function and other clinical factors. The prescriber selects the appropriate strength, frequency and duration for each individual case.

Safety data for levofloxacin in pregnancy are limited, and the drug is generally avoided unless the potential benefit outweighs the risk. It is excreted in breast milk, so caution is advised for nursing mothers, and a healthcare professional should evaluate the need for therapy.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levofloxacin is the L‑isomer of ofloxacin and offers higher potency with once‑daily dosing for many infections. Compared with older fluoroquinolones, it often provides broader coverage against Gram‑negative organisms and a more favorable safety profile, though class‑related risks such as tendon injury remain.

Levofloxacin Krka tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Do not store in humid environments or expose the product to excessive heat.

Levofloxacin Krka is taken orally, usually with a full glass of water. It can be taken with or without food, but antacids containing aluminum or magnesium should be spaced at least two hours apart to avoid reduced absorption.

Serious risks include tendon rupture or tendinitis, especially in older adults or those on corticosteroids; QT interval prolongation leading to cardiac arrhythmias; severe allergic reactions such as anaphylaxis; Clostridioides difficile‑associated colitis; peripheral neuropathy; and hepatic dysfunction.

Levofloxacin should be avoided in patients with a known hypersensitivity to fluoroquinolones, a history of tendon disorders related to quinolone use, those taking medications that significantly prolong the QT interval, and in pregnant women unless no safer alternative exists.